MedPage Today August 5, 2024
— Colorectal cancer screening accounted for 64% of the total amount
The cost of initial cancer screening in the U.S. was estimated to be over $43 billion in 2021, which was less than the reported annual cost of cancer treatment in the first year after diagnosis, according to a modeling study.
Using national healthcare survey and cost resources data, the total healthcare system costs for initial breast, cervical, colorectal, lung, and prostate cancer screening were estimated at $43.2 billion in 2021, reported Michael T. Halpern, MD, PhD, of the National Cancer Institute, and colleagues.
Of note, colorectal cancer screening accounted for 63.6% of the total amount, at $27.5 billion, with screening colonoscopy representing about 55% of the total, they noted...